A platform immunoassay for the quantification of biotherapeutics with glycine-serine linkers

Alexander Pöhler, Michael Antony, Janine Faigle, Gregor Jordan, Roland F Staack, Gregor P Lotz · 2024

Read A platform immunoassay for the quantification of biotherapeutics with glycine-serine linkers by Alexander Pöhler, Michael Antony, Janine Faigle, Gregor Jordan, Roland F Staack, Gregor P Lotz (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11703356.txt.

Description

Alexander Pöhler and co-authors developed a platform test to measure a class of lab-made drugs in 2024. Early drug work needs fast measures of how much drug is in the body. A shared test helps when custom reagents for each new drug are not yet ready.

Their test targets a common linker, a short glycine-serine chain that joins parts of many multi-part drugs. The test passed checks for accuracy and precision. It measures total drug levels. Tests for blocking by anti-drug antibodies or by free target showed no effect for one drug, but a possible effect for another. The authors advise checking that blocking for each new drug that uses the platform.

Catalog record

CREATORAlexander Pöhler, Michael Antony, Janine Faigle, Gregor Jordan, Roland F Staack, Gregor P Lotz
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11703356

Browse the full library · About the Tower of Babel